SIRT3 and liver cancer: Recent research has shown that nonhistone CCNE2 promotes liver cancer cell proliferation, migration, and invasion through lactylation, while NAD‐dependent deacetylase SIRT3 can remove CCNE2 lactylation, thereby regulating the cell cycle and impeding liver cancer progression.